Skip to main content

Drug-protein binding interferences caused by the plasticizer TBEP.

Devine JE

Publication: Clin Biochem (1984) • Vol 17 • Page 345-7PMID: 6518648View on PubMed

Purpose

The purpose of this paper was to determine the effects of contact with tris (2-butoxyethyl) phosphate (TBEP) containing stoppers on apparent concentrations of therapeutic drugs in blood.

Conclusion

Storage of blood in contact with TBEP containing stoppers resulted in 11-32% and 10-18% decreases in apparent quinidine and lidocaine concentrations, respectively. There was a larger decrease in specimens spiked with a low dose compared with higher doses of quinidine or lidocaine. TBEP also caused a decrease in the percentage of free lidocaine and bound theophylline. When lower than normal levels of alpha-l-acid glycoprotein (AAG) were present in the plasma, the effects of TBEP on measured lidocaine concentrations were much smaller.

Studies (1)

Purpose

The purpose of this study was to determine the effects of contact with TBEP containing stoppers on apparent concentrations of therapeutic drugs in blood. Donor blood was spiked with lidocaine, theophylline, and quinidine.

Summary of Findings

Storage of blood in contact with TBEP containing stoppers resulted in 11-32% and 10-18% decreases in apparent quinidine and lidocaine concentrations, respectively. There was a larger decrease in specimens spiked with low doses rather than higher doses of quinidine or lidocaine. TBEP also caused a decrease in the percentage of free lidocaine and bound theophylline. When lower than normal levels of AAG were present in the plasma, the effects of TBEP on measured lidocaine concentrations were much smaller.

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Not specified
  • Platforms

    Small moleculeImmunoassay
    Small moleculeClinical chemistry/auto analyzer
    Small moleculeEquilibrium dialysis
    Small moleculeGC- flame ionization
    GlycoproteinClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionBiomarker level
    0.2 g/L AAG (below normal)
    0.48 g/L AAG (normal)
    0.62 g/L AAG (normal)
    Biospecimen AcquisitionAnticoagulant
    Heparin
    StorageTime at room temperature
    2 h
    StorageType of storage container
    Glass tube with teflon coated screw cap
    Red-stoppered (containing TBEP) tube
    Red-stoppered (no TBEP) tube